Publication of a Prospectus

RNS Number : 9078C
Alkemy Capital Investments PLC
25 February 2022
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS AN ADVERTISEMENT AND IS NOT A PROSPECTUS AND NOT AN OFFER FOR SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW. INVESTORS SHOULD NOT PURCHASE OR SUBSCRIBE FOR ANY SHARES REFERRED TO IN THIS ANNOUNCEMENT EXCEPT ON THE BASIS OF INFORMATION IN THE PROSPECTUS (THE "PROSPECTUS") PUBLISHED BY ALKEMY CAPITAL INVESTMENT PLC, IN CONNECTION WITH THE PROPOSED ADMISSION OF ITS ORDINARY SHARES TO THE STANDARD LISTING SEGMENT OF THE OFFICIAL LIST OF THE FINANCIAL CONDUCT AUTHORITY AND TO TRADING ON THE MAIN MARKET FOR LISTED SECURITIES OF LONDON STOCK EXCHANGE PLC (THE "LONDON STOCK EXCHANGE" OR "LSE") (TOGETHER, "ADMISSION"). THE PROSPECTUS IS AVAILABLE ON THE COMPANY'S WEBSITE AT WWW.ALKEMY CAPITAL.CO.UK.

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS NOT FOR RELEASE,
PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW.

 

25 February 2022

 

Alkemy Capital Investments Plc

("Alkemy" or the "Company)

 

Publication of Prospectus

 

Alkemy is pleased to announce that its prospectus (the "Prospectus") in support of its intention to re-list on the London Stock Exchange has been approved by the Financial Conduct Authority and was published today.

 

The Prospectus is being issued in connection with the Company's application for admission of its entire issued share capital, being 5,999,999 ordinary shares or £0.02 each ("Ordinary Shares") to the Standard segment of the Official List and to trading on the London Stock Exchange's Main Market for listed securities ("Re-admission").

 

The Company expects that Re-admission will become effective and that dealings in the Ordinary Shares will commence on 2 March 2022 at 8.00 a.m. (London time) under the ticker symbol: ALK .

 

A copy of the Prospectus will be submitted to the National Storage Mechanism and will shortly be available for inspection (subject to securities laws) at www.data.fca.org.uk/#/nsm/nationalstoragemechanism .

 

The Prospectus is available on the Company's website at www.alkemycapital.co.uk .  

 

 

** Ends **

 

For further information, please contact:
 

Sam Quinn  
Director, Alkemy Capital Investments Plc
Telephone: 0207 317 0636

Email: info@alkemycapital.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIZZGZZDKFGZZM
UK 100

Latest directors dealings